Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionHuman antibody directed against human heparin-binding epidermal growth factor-like growth factor (HB-EGF)
Molecular Target Heparin-binding EGF-like growth factor (HBEGF) (DTR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today